Partially-guided Protocol for Maxillary Overdentures Retained by Ti-Zr One-piece Mini Implants
Launched by UNIVERSIDADE FEDERAL DE GOIAS · Oct 6, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new method for placing mini implants in the upper jaw (maxilla) to help secure dentures for people who no longer have their natural teeth. Participants in this study will receive six mini implants, which are small devices that act like tooth roots, to hold a type of denture called an overdenture more firmly in place. The goal is to see how accurately these implants can be placed using a partially-guided technique, which means the process is planned out in advance to ensure the best positioning and fit.
To join the trial, participants must be at least 60 years old and have a healed upper jaw that is ready for implants. They should currently be using a complete upper denture and have enough bone in their jaw to support the mini implants. Before joining, individuals will be screened for certain health conditions, such as uncontrolled diabetes or severe oral hygiene issues, as these may prevent them from participating. Throughout the study, participants can expect to have their oral health quality of life assessed and will be monitored for the success of the implants and any potential complications. This trial aims to improve the experience of wearing dentures for those in need.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 60 years of age
- • healed dentulous maxillary arch (minimum of twelve weeks since the last extraction)
- • wearing a complete maxillary denture evaluated as sufficient for surgical planning
- • minimal ridge dimensions of 5.4 mm (width) by 12 mm (height) in the anterior and premolar maxillary area
- • bone dimensions allowing the placement of one-piece implants with a 2.4 mm-diameter and minimum length of 10 mm.
- • general health condition should be a physical status ASA1 or ASA2.
- Exclusion Criteria:
- • inability to perform adequate oral hygiene
- • incapability to provide written informed consent and compliance to the protocol
- • any contraindication for oral surgery such as but not limited to,
- • uncontrolled diabetes
- • immunosuppression
- • radiation or chemotherapy
- • antiresorptive medication such as bisphosphonates
- • presence of dental, periodontal or peri-implant disease in the opposing arch
- • presence of a conventional complete denture in the opposing arch (mandible)
- • presence of an insufficient partial removable denture or implant-overdenture in the opposing arch, which cannot be rendered sufficient by a reline
- • heavy smoking habit with \> 20 cig/d
- • reported severe bruxism or clenching habits
- • clinically present oro-facial pain
- • depression with a Geriatric Depression Scale above 12
- • xerostomia with a stimulated salivary flow rate inferior to 0.7 ml/min
- • ridge morphology type IV (Cawood and Howell, 1988)
- • defects requiring bone augmentation procedures, or unhealthy soft tissues.
About Universidade Federal De Goias
The Universidade Federal de Goiás (UFG) is a prominent Brazilian higher education institution renowned for its commitment to advancing research and healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UFG aims to enhance medical knowledge and improve patient outcomes by conducting rigorous, ethical studies across various therapeutic areas. The university fosters a research environment that combines academic excellence with community engagement, ensuring that its clinical trials not only contribute to scientific advancement but also address pressing health challenges faced by diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Cláudio R Leles, PhD
Principal Investigator
Universidade Federal de Goias
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported